Informations sur le produit
Ledipasvir D-tartrate is a synthetic, broad-spectrum antiviral agent that is used to treat hepatitis C virus (HCV) infection. It inhibits the HCV NS5A protein, which is needed for viral replication and assembly. Ledipasvir D-tartrate was discovered by scientists at Gilead Sciences. The drug was approved for use in combination with sofosbuvir in 2017 as an oral treatment for chronic HCV infection.
Ledipasvir D-tartrate binds to the NS5A protein and blocks its ability to function, thereby inhibiting viral replication. Ledipasvir D-tartrate also prevents the production of new viruses by blocking the activity of other proteins needed for viral assembly and release from infected cells.
It is effective against a wide variety of microorganisms, including bacteria, fungi, and parasites. It has been shown to be active against methicillin-resistant Staphylococ
Propriétés chimiques
Question d’ordre technique sur : 3D-FL180961 Ledipasvir D-tartrate
Si vous souhaitez demander un devis ou passer commande, veuillez plutôt ajouter les produits souhaités à votre panier, puis demander un devis ou passer commande à partir de votre panier. C'est une méthode plus rapide, plus économique, et vous pourrez bénéficier des remises disponibles ainsi que d'autres avantages
